Publications by authors named "Elsa Do Carmo"
Euro Surveill
January 2024
Article Synopsis
- Luxembourg's introduction of nirsevimab immunisation for RSV led to an impressive neonatal coverage of 84% in 2023.
- The number of paediatric RSV-related hospitalisations for infants under 6 months significantly decreased, dropping from 232 in 2022 to 72 in 2023.
- Additionally, hospital stays shortened and the average age of hospitalised children increased, indicating that nirsevimab effectively reduced severe RSV infections and lessened the burden on healthcare.
